Siemens Antibody Test Quality Control Kit Atellica® IM SARS-CoV-2 IgG Positive Level / Negative Level 2 X 2 X 2 mL - Each - 11207388-EA

Siemens Antibody Test Quality Control Kit Atellica® IM SARS-CoV-2 IgG Positive Level / Negative Level 2 X 2 X 2 mL - Each - 11207388-EA

Regular price $367.99
Sale price $367.99 Regular price
OFF Sold out
Shipping calculated at checkout.

50 In stock

Estimated deliver: Jan23 - Jan26

Free Shipping & Returns: On orders above $79

Estimated deliver 5-7 days

  • American Express
  • Diners Club
  • Discover
  • Mastercard
  • Shop Pay
  • Visa
View full details
Reviews

Siemens Antibody Test Quality Control Kit Atellica® IM SARS-CoV-2 IgG Positive Level / Negative L...

Item Id 1185715
MF Id# 11207388
Brand Atellica® IM
Manufacturer Siemens
Country of Origin United States
Application Quality Control Kit
Container Type Vial
For Use With For Monitoring Precision and Accuracy of the Atellica® IM SARS-CoV-2 IgG (sCOVG) Assay using the Atellica® IM Analyzer
Form Liquid
Is_Active_Vendor Y
Is_DSCSA N
Is_Discontinued N
Is_Medical_Device N
Levels Positive Level / Negative Level
Lot_Tracking_Flag N
On_Allocation N
Product Dating McKesson Acceptable Dating: we will ship >= 30 days
Storage Requirements Requires Refrigeration
Supplier_ID 3849247
Test Name SARS-CoV-2 IgG
Test Type Antibody Test
UNSPSC Code 41116145
Volume 2 X 2 X 2 mL

Features

  • The Atellica IM SARS-CoV-2 IgG is for use under Emergency Use Authorization Only: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-serology-and-other-adaptive-immune-response-tests-sars-cov-2
  • Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C 263a, that meet requirements to perform moderate or high complexity tests
  • The Atellica® IM SARS-CoV-2 IgG Quality Control (sCOVG QC) is for in vitro diagnostic use in monitoring the precision and accuracy of the Atellica® IM SARS-CoV-2 IgG (sCOVG) assay using the Atellica® IM Analyzer
  • Negative results do not preclude acute SARS-CoV-2 infection; if acute infection is suspected, direct testing for SARS-CoV-2 is necessary
  • Results from antibody testing should not be used to diagnose or exclude acute SARSCoV-2 infection
  • Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains
  • Laboratories within the United States and its territories are required to report all positive results to the appropriate public health authorities
  • 2 vials x 2.0 mL negative control, 2 vials x 2.0 mL positive control
  • Quality control materials are liquid and ready to use

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
About your query!
Recently Viewed